Translate Bio, Inc. logo
Translate Bio, Inc. TBIO

Translate Bio, Inc. Net Debt 2011-2026 | TBIO

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Translate Bio, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-279 M -72 M -55.2 M -48.1 M -57.7 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-48.1 M -279 M -102 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Biotechnology industry

Issuer Net Debt Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
163 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
12.6 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
-1.06 B - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
-340 M - - $ 3.67 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-6.17 M - -18.52 % $ 27.3 M britainBritain
AlloVir AlloVir
ALVR
-62.7 M - 4.14 % $ 49.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
-402 M - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-2.77 M $ 0.88 -1.69 % $ 6.47 M chinaChina
Biophytis SA Biophytis SA
BPTS
-4.01 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
2.27 M - 2.54 % $ 160 B franceFrance
Aquestive Therapeutics Aquestive Therapeutics
AQST
-75.5 M $ 4.1 1.23 % $ 438 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
-83 M $ 22.45 1.13 % $ 3.72 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-824 K - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
-68.5 M - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-56.5 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-657 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
9.86 B - - $ 96.9 B britainBritain
Atreca Atreca
BCEL
33.1 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
-60.5 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
-56.5 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
3.42 M - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
-206 M - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
-42.5 M - - $ 3.74 B usaUSA
Cerus Corporation Cerus Corporation
CERS
-6.9 M $ 2.03 5.73 % $ 387 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
246 M - - - russiaRussia
Caladrius Biosciences Caladrius Biosciences
CLBS
-22.3 M - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-12.1 M - - $ 231 M usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
-5.43 M $ 13.64 9.82 % $ 1.81 B australiaAustralia
Aeterna Zentaris Aeterna Zentaris
AEZS
-65.1 M - 5.93 % $ 314 M canadaCanada
BioNTech SE BioNTech SE
BNTX
-973 M $ 103.45 1.85 % $ 27.2 B germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
533 K - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-30.2 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-36 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-57.6 M - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-31.2 M - 1.93 % $ 17.4 M usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
-120 M $ 1.44 -3.36 % $ 235 M franceFrance
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-65.3 M - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
-92.9 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
-25 M - - $ 28.6 M usaUSA
Editas Medicine Editas Medicine
EDIT
-87 M $ 3.0 6.38 % $ 266 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
-7.74 M $ 18.27 14.94 % $ 58.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-3.5 M $ 3.19 6.69 % $ 5.25 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
10.2 M - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
-9.94 M - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-783 M - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-12 M - -11.43 % $ 502 K usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-49.4 M - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-5.53 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
-33.8 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
-49.6 M - -13.39 % $ 1.45 M usaUSA